Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07119658 · ClinicalTrials.gov registry record · NA

Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial

A NA study of Hypertension and Diabetes, sponsored by Indiana University.

Recruiting
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT07119658: Recruiting NA study of Hypertension and Diabetes, sponsored by Indiana University.

NCT07119658 is a NA study of Hypertension and Diabetes that is actively recruiting participants, run by Indiana University. The registered enrollment target is 20 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07119658, a NA study of Hypertension and Diabetes, is actively recruiting participants, sponsored by Indiana University.

RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

The objective of this study is to pilot a multifaceted, optimized intervention for metabolic syndrome (MetS) in emergency department patients to establish feasibility. Participants (n=20) will be randomized to intervention or control (usual care). The composite intervention will include an educational video outlining the adverse effects of MetS and the benefit of walking, a written exercise prescription with a defined goal of walking 150 minutes per week, a Fitbit accelerometer device, resources for healthy eating practices, periodic text message reminders, and an urgent referral to primary care and our health system's Healthy Me clinic for follow-up visit. Investigators hypothesize that this approach will change patient understanding and motivation to increase physical activity and healthy eating habits.

Primary Outcome

Investigators will collect activity data utilizing a Fitbit accelerometer device. The primary outcome will be the mean number of daily steps averaged from 3 months of monitoring, compared between groups.

Interventions

  • BEHAVIORAL Composite intervention to address MetS

Study Locations (1)

Indiana

  • Sidney & Lois Eskenazi Hospital - Indianapolis

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2025-07-08
Est. Completion 2026-07
Phase NA
Indiana University

890 total trials

What NCT07119658 shows while recruiting

NCT07119658 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (99% lower).

The record links to 8 conditions, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Composite intervention to address MetS is the first listed.

NCT07119658 reports a single indexed study location in Indiana.

Frequently Asked Questions

What is clinical trial NCT07119658 about?

NCT07119658 is a clinical study titled "Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial". The objective of this study is to pilot a multifaceted, optimized intervention for metabolic syndrome (MetS) in emergency department patients to establish feasibility. Participants (n=20) will be randomized to intervention or control (usual care). The composite intervention will include an education...

What is the current status of trial NCT07119658?

This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2025-07-08. Estimated completion is 2026-07.

What conditions does trial NCT07119658 study?

This clinical trial studies the following conditions: Hypertension, Diabetes, Metabolic Syndrome, Dyslipidemia, Hyperglycemia.

What interventions are being tested in trial NCT07119658?

The interventions under investigation include: Composite intervention to address MetS (BEHAVIORAL).

Who is sponsoring clinical trial NCT07119658?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07119658 being conducted?

This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07119658's enrollment target sits among peer trials

20 438th of 470 higher than 24 of 470 other Hypertension trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07119658, the US trial registry maintained by the National Library of Medicine. NCT07119658 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.